Location History:
- Helsingør, DK (2011 - 2015)
- Helsingoer, DK (2019 - 2022)
Company Filing History:
Years Active: 2011-2025
Title: Bo Kvolsbjerg: Innovator in Drug Delivery Technology
Introduction
Bo Kvolsbjerg is a notable inventor based in Helsingør, Denmark. He has made significant contributions to the field of drug delivery technology, holding a total of seven patents. His work focuses on improving the efficiency and effectiveness of medical devices used for administering liquid drugs.
Latest Patents
Among his latest patents is an innovative injection device designed for delivering a liquid drug. This pre-filled injection device features a non-removable cartridge and utilizes a threaded piston rod that moves helically within a nut secured to the housing structure. This design allows for the elimination of air gaps during assembly, ensuring a more reliable drug delivery system. Another significant patent is for a flow communication unit that establishes flow communication from a multi-use drug delivery device to a flow conducting device. This unit is adaptable for both unconnected and connected configurations, enabling extended use of the drug delivery device, which is essential for administering multiple doses of liquid drug formulations.
Career Highlights
Bo Kvolsbjerg is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to focus on developing advanced drug delivery systems that enhance patient care and treatment outcomes.
Collaborations
Throughout his career, Bo has collaborated with several talented individuals, including Claus Schmidt Møller and Henrik Bengtsson. These collaborations have contributed to the innovative solutions he has developed in the field of drug delivery.
Conclusion
Bo Kvolsbjerg is a prominent figure in the realm of medical device innovation, particularly in drug delivery technology. His patents reflect a commitment to improving healthcare solutions, making a significant impact on patient treatment options.